GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VitaSpring Biomedical Co Ltd (OTCPK:VSBC) » Definitions » Operating Margin %

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Operating Margin % : 0.00% (As of Oct. 2022)


View and export this data going back to 2019. Start your Free Trial

What is VitaSpring Biomedical Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. VitaSpring Biomedical Co's Operating Income for the three months ended in Oct. 2022 was $-0.18 Mil. VitaSpring Biomedical Co's Revenue for the three months ended in Oct. 2022 was $0.00 Mil. Therefore, VitaSpring Biomedical Co's Operating Margin % for the quarter that ended in Oct. 2022 was 0.00%.

The historical rank and industry rank for VitaSpring Biomedical Co's Operating Margin % or its related term are showing as below:


VSBC's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -168.78
* Ranked among companies with meaningful Operating Margin % only.

VitaSpring Biomedical Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

VitaSpring Biomedical Co's Operating Income for the three months ended in Oct. 2022 was $-0.18 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Oct. 2022 was $1.18 Mil.


VitaSpring Biomedical Co Operating Margin % Historical Data

The historical data trend for VitaSpring Biomedical Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VitaSpring Biomedical Co Operating Margin % Chart

VitaSpring Biomedical Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22
Operating Margin %
Get a 7-Day Free Trial -37.50 -129.41 -126.67 -171.37 26.42

VitaSpring Biomedical Co Quarterly Data
Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.50 34.14 23.09 - -

Competitive Comparison of VitaSpring Biomedical Co's Operating Margin %

For the Biotechnology subindustry, VitaSpring Biomedical Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VitaSpring Biomedical Co's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's Operating Margin % falls into.



VitaSpring Biomedical Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

VitaSpring Biomedical Co's Operating Margin % for the fiscal year that ended in Jan. 2022 is calculated as

Operating Margin %=Operating Income (A: Jan. 2022 ) / Revenue (A: Jan. 2022 )
=1.483 / 5.613
=26.42 %

VitaSpring Biomedical Co's Operating Margin % for the quarter that ended in Oct. 2022 is calculated as

Operating Margin %=Operating Income (Q: Oct. 2022 ) / Revenue (Q: Oct. 2022 )
=-0.183 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VitaSpring Biomedical Co  (OTCPK:VSBC) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


VitaSpring Biomedical Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


VitaSpring Biomedical Co (VitaSpring Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
400 Spectrum Center Dr. No. 1620, Irvine, CA, USA, 92618
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Headlines

No Headlines